Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Thalassemia MajorThalassemia IntermediaPulmonary Arterial Hypertension
Interventions
OTHER

Physician standard-of-care according to ESC/ERS Guidelines

Physician standard-of-care

Trial Locations (8)

8100

U.O.C- Cardiologia Ospedale San Francesco, Nuoro

10043

SCDU Microcitemie-Pediatria A.O. Universitaria S.Luigi Gonzaga di Orbassano, Orbassano

16128

Centro della Microcitemia e delle Anemie Congenite -Ematologia e Cardiologia E.O. Ospedali Galliera, Genoa

20162

Centro Anemie Congenite Università di Milano IRCCS Ospedale Maggiore Policlinico, Milan

72100

Divisione di Ematologia Ospedale Perrino, Brindisi

80131

"Dipartimento di pediatria F.Fede A.O. Universitaria FedericoII di Napoli", Napoli

09123

Clinica pediatrica Ospedale Microcitemico, Cagliari

DH Microcitemia dell'adulto Ospedale Microcitemico, Cagliari

All Listed Sponsors
lead

Ente Ospedaliero Ospedali Galliera

OTHER

NCT01496963 - Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia | Biotech Hunter | Biotech Hunter